Protein and cell therapy for lecithin-cholesterol acyltransferase (LCAT) deficiency
Lecithin-cholesterol acyltransferase (LCAT) is an enzyme principally secreted by the liver into the circulation where it esterifies cholesterol and plays a key role in high- density lipoprotein (HDL) metabolism. In familial and acquired (liver disease) LCAT deficiency, the failure to esterify choles...
Main Author: | Low, J. K. |
---|---|
Published: |
University College London (University of London)
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.564542 |
Similar Items
-
Attempts to generate atheroprotective lecithin-cholesterol acyltransferase (LCAT) phenotypes by chimeraplasty
by: Sperber, Galia
Published: (2006) -
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
by: J A Kuivenhoven, et al.
Published: (1997-02-01) -
Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
by: J J Albers, et al.
Published: (1981-11-01) -
Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344–>Ser)
by: K Moriyama, et al.
Published: (1995-11-01) -
Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency
by: X P Yang, et al.
Published: (1997-03-01)